🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Switzerland / NCT05728840
Recruiting Not applicable

Virtual-reality Exercises for Alleviating Attention Deficits in Patients With Acquired Brain Injury

NCT05728840 · tracked via the Priya Life Science Switzerland tracker
Sponsor
Mindmaze SA
Phase
Not applicable
Started
2023-02-15
Last updated
2026-02-17

Condition(s) studied

StrokeAttention Disorder

Investigational drug(s) / intervention(s)

Immersive virtual reality gamified cognitive activitiesDouble neuropsychological standard activities

Immersive virtual reality gamified cognitive activities: This intervention will include 20 sessions of training with the experimental rehabilitation program using immersive VR cognitive gamified activities, in addition to the standard of care.

Double neuropsychological standard activities: This intervention will include 20 sessions of training using a standard neuropsychological rehabilitation program, in addition to the standard of care.

Study summary

Stroke is the leading cause of long-term disability with an increasing incidence, especially in young adults. Among the cognitive difficulties following brain damage, deficits in attention are frequent and pervasive, affecting between 46% and 92% of stroke survivors. The current project targets patients with acquired brain injury, including stroke, traumatic brain injury, and brain tumor. The main objective of this study is to evaluate the use and the efficacy of a training program targeting attention and executive function difficulties, using gamified and digitized versions in virtual reality of standard cognitive exercises for patients with brain lesions.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Time from stroke onset \< 1 month * Objective pathological performance on at least one standardized test or subtest on attention during standard neuropsychological evaluation * Brain injury documented by routine neuroradiological examination (computed tomography or magnetic resonance imaging scan) * Able to give informed consent as documented by signature * Age \>= 18 years old Exclusion Criteria: * Epilepsy * Inability or contraindications to undergo the investigated intervention * Major psychiatric co-morbidity * Major neurocognitive deficits (e.g. dementia) * Incapacity to discriminate colors * General cognitive state preventing to understand and perform the tasks * Decision to not be informed of incidental findings

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University of Lausanne Hospitals Lausanne Switzerland Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05728840 on ClinicalTrials.gov ↗ ← All trials in Switzerland